DSpace at RU >

Search Results

Results 1-50 of 114.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	The burden of childhood psoriasis	Jager, M.E.A. de; Jong, E.M.G.J. de; Evers, A.W.M.; Kerkhof, P.C.M. van de; Seijger, M.M.B.
	2011	Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab	Lumig, P.P.M. van; Driessen, R.J.B.; Roelofs-Thijssen, M.A.; Boezeman, J.B.M.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2011	Juvenile psoriasis in European and Asian children: similarities and differences	Chiam, L.Y.; Jager, M.E.A. de; Giam, Y.C.; Jong, E.M. de; Kerkhof, P.C. van de; Seijger, M.M.B.
	2011	An intrapatient comparison of quality of life in psoriasis in childhood and adulthood	Jager, M.E.A. de; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de; Evers, A.W.M.; Seijger, M.M.B.
	2011	Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists	Vries, H.S. de; Oijen, M.G.H. van; Driessen, R.J.B.; Jong, E.M. de; Creemers, M.C.W.; Kievit, W.; Jong, D.J. de
	2010	Samenvatting richtlijn vasculitis : de huid	Jong, E.M.G.J. de; Thio, H.B.; Stegeman, C.A.
	2010	Löffler syndrome caused by extensive cutaneous larva migrans: A case report and review of the literature	Booij, M. te; Jong, E.M.G.J. de; Bovenschen, H.J.
	2010	Daily practice assessment of liver injury in patients with psoriasis on methotrexate.	Driessen, R.J.B.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2010	Wenn Stress unter die Haut geht : Cortisol und Stress in Psoriasis	Evers, A.W.M.; Verhoeven, E.W.M.; Kraaimaat, F.W.; Jong, E.M.G.J. de; Brouwer, S.J.M. de; Schalkwijk, J.; Sweep, C.G.J.; Kerkhof, P.C.M. van de
	2010	How stress gets under the skin: cortisol and stress reactivity in psoriasis.	Evers, A.W.M.; Verhoeven, E.W.M.; Kraaimaat, F.W.; Jong, E.M.G.J. de; Brouwer, S.J.M. de; Schalkwijk, J.; Sweep, F.C.; Kerkhof, P.C.M. van de
	2010	A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores.	Jager, M.E.A. de; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de; Seijger, M.M.B.
	2010	Efficacy and safety of treatments for childhood psoriasis: a systematic literature review.	Jager, M.E.A. de; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de; Seijger, M.M.B.
	2010	Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion.	Jager, M.E.A. de; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de; Seijger, M.M.B.
	2010	No evidence found that childhood onset of psoriasis influences disease severity, future body mass index or type of treatments used	Jager, M.E.A. de; Jong, E.M.G.J. de; Meeuwis, K.A.P.; Kerkhof, P.C.M. van de; Seijger, M.M.B.
	2010	Analysis of 4-year Dutch reimbursement application data of biological therapies for psoriatic arthritis.	Driessen, R.J.B.; Jong, E.M.G.J. de; Salemink, G.W.; Burer, J.H.G.; Kerkhof, P.C.M. van de; Hoogen, F.H.J. van den
	2010	Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.	Lumig, P.P.M. van; Lecluse, L.L.; Driessen, R.J.B.; Spuls, P.I.; Boezeman, J.B.M.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2010	The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics.	Driessen, R.J.B.; Bisschops, Laurens; Adang, E.M.M.; Evers, A.W.M.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2010	Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.	Lecluse, L.L.; Driessen, R.J.B.; Spuls, P.I.; Jong, E.M.G.J. de; Stapel, S.O.; Doorn, M.B. van; Bos, J.D.; Wolbink, G.J.
	2009	E-health-behandelingen bij de chronische lichamelijke aandoeningen. Het patiëntenperspectief.	Evers, A.W.M.; Burik, A. van; Goor, S.S. van de; Hoeve, D.; Duller, P.; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de
	2009	Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: a pilot study.	Lingen, R.G. van; Jong, E.M.G.J. de; Berends, M.A.M.; Seijger, M.M.B.; Erp, P.E.J. van; Kerkhof, P.C.M. van de
	2009	Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement	Lingen, R.G. van; Erp, P.E.J. van; Seyger, M.M.B.; Jong, E.M.G.J. de; Boer-van Huizen, R.T. de; Driessen, R.J.B.; Kerkhof, P.C.M. van de
	2009	Effect of daily stressors on psoriasis: a prospective study.	Verhoeven, E.W.M.; Kraaimaat, F.W.; Jong, E.M.G.J. de; Schalkwijk, J.; Kerkhof, P.C.M. van de; Evers, A.W.M.
	2009	Erythroderma in two patients with psoriasis upon discontinuation of efalizumab treatment.	Kop, E.N.; Korver, J.E.M.; Ruysevelt, D. Van; Jong, E.M.G.J. de; Valk, P.G.M. van der; Kerkhof, P.C.M. van de
	2009	Validation of clinical and image skin scoring systems for a single chronic discoid lupus erythematosus lesion.	Erceg, A.; Jong, E.M.G.J. de; Lingen, R.G. van; Boo, T.M. de; Kerkhof, P.C.M. van de; Seyger, M.M.B.
	2009	Epidemiology and prescribed treatments in childhood psoriasis: a survey among medical professionals.	Jager, M.E.A. de; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de; Seyger, M.M.B.
	2009	Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study.	Kroft, E.B.M.; Groeneveld, T.J.; Seyger, M.M.B.; Jong, E.M.G.J. de
	2009	Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.	Driessen, R.J.B.; Boezeman, J.B.M.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2009	Psychological distress in patients with morphea and eosinophilic fasciitis.	Kroft, E.B.M.; Jong, E.M.G.J. de; Evers, A.W.M.
	2009	Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis.	Evers, A.W.M.; Duller, P.; Jong, E.M.G.J. de; Kooijmans-Otero, M.E.; Verhaak, C.M.; Valk, P.G.M. van der; Kerkhof, P.C.M. van de; Kraaimaat, F.W.
	2009	Individual differences in the effect of daily stressors on psoriasis: a prospective study.	Verhoeven, E.W.M.; Kraaimaat, F.W.; Jong, E.M.G.J. de; Schalkwijk, J.; Kerkhof, P.C.M. van de; Evers, A.W.M.
	2009	Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.	Jansen, P.A.M.; Olthuis, D.; Hollox, E.J.; Kamsteeg, M.; Tjabringa, G.S.; Jongh, G.J. de; Vlijmen-Willems, I.M.J.J. van; Bergboer, J.G.M.; Rossum, M.M. van; Jong, E.M.G.J. de; Heijer, M. den; Evers, A.W.M.; Bergers, A.M.G.; Armour, J.A.; Zeeuwen, P.L.J.M.; Schalkwijk, J.
	2009	Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.	Kroft, E.B.M.; Creemers, M.C.W.; Hoogen, F.H.J. van den; Boezeman, J.B.M.; Jong, E.M.G.J. de
	2009	Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus.	Erceg, A.; Bovenschen, H.J.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de; Seyger, M.M.B.
	2009	Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.	Driessen, R.J.B.; Boezeman, J.B.M.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2008	Evaluation of the reimbursement criteria for biological therapies for psoriasis in the Netherlands.	Wakkee, M.; Thio, H.B.; Spuls, P.I.; Jong, E.M.G.J. de; Nijsten, T.
	2008	Scleredema diabeticorum case series: successful treatment with UV-A1.	Kroft, E.B.M.; Jong, E.M.G.J. de
	2008	Physical burden of symptoms in patients with localized scleroderma and eosinophilic fasciitis.	Kroft, E.B.M.; Jong, E.M.G.J. de; Evers, A.W.M.
	2008	‘Jeuk is erger dan pijn’ : Diagnostiek en behandeling van jeuk bij chronische huidaandoeningen	Evers, A.W.M.; Duller, P.; Verhoeven, E.W.M.; Laarhoven, A.I.M. van; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de
	2008	Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis.	Driessen, R.J.B.; Jong, E.M.G.J. de; Rie, M.A. de; Salemink, G.W.; Kerkhof, P.C.M. van de
	2008	Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: A pilot study	Lingen, R.G. van; Jong, E.M.G.J. de; Berends, M.A.M.; Seyger, M.M.B.; Erp, P.E.J. van; Kerkhof, P.C.M. van de
	2008	Biopsychosocial mechanisms of chronic itch in patients with skin diseases: a review.	Verhoeven, E.W.M.; Klerk, S de; Kraaimaat, F.W.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de; Evers, A.W.M.
	2008	Reduced CD26bright expression of peripheral blood CD8+ T-cell subsets in psoriatic patients.	Lingen, R.G. van; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de; Seyger, M.M.B.; Boezeman, J.B.M.; Erp, P.E.J. van
	2008	Morphea profunda presenting as a neuromuscular mimic.	Voermans, N.C.; Pillen, S.; Jong, E.M.G.J. de; Creemers, M.C.W.; Lammens, M.M.Y.; Alfen, N. van
	2008	Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.	Lingen, R.G. van; Poll, M.K.; Seyger, M.M.B.; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de; Erp, P.E.J. van
	2008	Nd: YAG laser (1,064 nm) fails to improve localized plaque type psoriasis: a clinical and immunohistochemical pilot study.	Lingen, R.G. van; Jong, E.M.G.J. de; Erp, P.E.J. van; Meeteren, WS van; Kerkhof, P.C.M. van de; Seyger, M.M.B.
	2008	Etanercept combined with methotrexate for high-need psoriasis.	Driessen, R.J.B.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2008	Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome.	Driessen, R.J.B.; Berends, M.A.M.; Boezeman, J.B.M.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2008	Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis.	Langewouters, A.M.G.; Erp, P.E.J. van; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de
	2008	The effect of alefacept on T-cell subsets and cells expressing NK receptors in lesional psoriatic skin: the effects of monotherapy and combination treatment with calcipotriol.	Vissers, W.H.P.M.; Duijnhoven, M. van; Erp, P.E.J. van; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de
	2008	Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies.	Lingen, R.G. van; Korver, J.E.M.; Kerkhof, P.C.M. van de; Berends, M.A.M.; Rens, D.W.A. van; Langewouters, A.M.G.; Boezeman, J.B.M.; Seyger, M.M.B.; Jong, E.M.G.J. de

1 2 3 next